10/31/2025CDE Invites Comment on Implementation Guidance for ICH Q8, Q9 and Q10 ...

10/31/2025GC Cell Licenses IASO Biotech's Multiple Myeloma CAR-T Therapy for Kor...

10/31/2025Haleon Gains Momentum in China as U.S. Sales Remain Weak

10/31/2025China Overhauls Drug Procurement and Reimbursement Framework to Balanc...

10/31/2025China Adds Novel Drugs Catalog to National BMI Talks for the First Tim...

10/31/2025Lumosa's Stroke Drug Achieves Phase IIb Success in China

10/31/2025Junshi's Toripalimab Becomes First Immunotherapy Approved for NPC in C...

10/31/2025Roche Strikes Over $1B Global Licensing Deal with Qyuns Therapeutics

10/31/2025Longwood Biopharma Secures Series B+ Funding to Accelerate Innovative ...

10/31/2025Sichuan Biokin Advances 11th ADC Candidate BL-M24D1 into Clinical Tria...

10/31/2025Bayer to Divest Avelox Assets to HSG in Deal Valued up to €260 Millio...

More>>

10/31/2025China's Biotech Deal Boom Tests Ethical Boundaries as Valuations Soar ...

10/29/2025China Pushes Ethical Limits in Global Biotech Race With Gene-Edited An...

10/22/2025Understanding China's Longevity Market: Industry Segments, Trends and ...

10/21/2025ESMO 2025 Highlights China's Strategic Leap in Oncology Innovation

10/17/2025Novo vs. KBP: Fraud or Due Diligence Slipup? (FierceBiotech)

10/13/2025First Drug Patent Term Extension Granted In China (Mondaq)

10/13/2025U.S. Senate Approves Revised China Biotech Competition Bill with Softe...

10/13/2025China's Innovative Drug Sector Secures Over CNY 4.2B in Q3 Financing, ...

9/23/2025Challenges and Opportunities in Oncology Drug Development and Clinical...

9/23/2025China's Edge over U.S. Biotech Was Never Scientific (Washington Post)

9/22/2025China's Role in Global Drug Approvals Expands as Regulatory Timelines ...

More>>